Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Papakonstantinou, M. Roth, G. Karakiulakis, S. Savic, M. Tamm, D. Stolz (Thessaloniki, Greece; Basel, Switzerland). Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation. Eur Respir J 2013; 42: Suppl. 57, 259

Member's Comments

No comment yet.

Related content which might interest you: Serum SP-A and SP-D levels in patients admitted to the hospital with acute COPD exacerbation Source: International Congress 2016 – Inflammatory biomarkers in airway diseases Year: 2016 Eosinophilia as marker of outcome in hospitalised patients with AECOPD Source: Annual Congress 2013 –COPD and infections Year: 2013 Increased circulating alveolar epithelial microparticles in COPD patients Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015 COPD exacerbation severity is associated with impaired macrophage phagocytosis of eosinophils Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 COPD exacerbation: Influence of severity and type of systemic inflammation on the hospitalizations rate Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Altered inflammasome activity in bacterial acute exacerbations of COPD (AECOPD) Source: Annual Congress 2013 –Biomarkers in asthma and COPD Year: 2013 Inflammation biomarkers of lung tissue damage in acute exacerbation of COPD patients Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013 The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013 Role of inflammatory biomarkers in COPD Source: International Congress 2016 – Systemic biomarkers Year: 2016 Neutrophil CD 64 expression as a diagnostic marker of pneumonia in patients with acute COPD exacerbation Source: International Congress 2014 – Markers Year: 2014 IL-17A is specifically elevated in NTHi-associated AECOPD and end-stage COPD Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015 Inflammatory serum profiles are consistent across independent exacerbations in COPD patients with a history of frequent exacerbations Source: International Congress 2015 – COPD: interesting notes Year: 2015 BNP level in patients with COPD exacerbations Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Relationship of blood eosinophil count to exacerbations in COPD Source: International Congress 2016 – Airway response to infection Year: 2016 Serum periostin in patients hospitalized for COPD exacerbations Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 MUC1-CT mediates corticosteroid responses in COPD Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action Year: 2016 Characterization of readmissions in patients hospitalized with COPD exacerbation Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Irisin is associated with severe exacerbations of COPD independently of lung function, comorbidities and exercise capacity Source: International Congress 2015 – Notable abstracts in COPD: variety Year: 2015 The role of biomarkers in predicting outcomes in acute exacerbations of chronic obstructive pulmonary disease (AECOPD) Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013 Recruitment of blood fibrocytes during acute exacerbations of chronic obstructive pulmonary disease through a CXCR4 dependent pathway Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease Year: 2015